ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      86.695
      -0.25%
      Bitcoin
      58,818.74
      -2.23%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Akers Biosciences Inc (AKER)

      7. Akers Biosciences Inc (AKER) News

      AKER

      Akers Biosciences (AKER)

      Akers Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AKER
      DateTimeSourceHeadlineSymbolCompany
      1:00PMiHub NewswireFeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent
      09/11/20206:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AKERAkers Biosciences Inc
      09/11/20205:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
      09/09/20204:56PMEdgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:AKERAkers Biosciences Inc
      09/08/20205:31PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AKERAkers Biosciences Inc
      09/01/20204:35PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AKERAkers Biosciences Inc
      08/31/20201:13PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AKERAkers Biosciences Inc
      08/28/20205:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
      08/27/20209:00AMGlobeNewswire Inc.Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept ResultsNASDAQ:AKERAkers Biosciences Inc
      08/26/20207:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AKERAkers Biosciences Inc
      08/18/20207:19AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AKERAkers Biosciences Inc
      08/13/20208:41AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AKERAkers Biosciences Inc
      08/11/20208:00AMGlobeNewswire Inc.Akers Biosciences Announces $6.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:AKERAkers Biosciences Inc
      07/27/20206:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
      07/23/20204:29PMEdgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:AKERAkers Biosciences Inc
      07/22/20205:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
      07/13/20205:11PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AKERAkers Biosciences Inc
      07/13/20208:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
      07/08/202011:49AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
      07/07/20209:00AMGlobeNewswire Inc.Akers Biosciences and Premas Biotech Announce Initiation of Animal StudiesNASDAQ:AKERAkers Biosciences Inc
      06/15/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AKERAkers Biosciences Inc
      06/05/20204:41PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:AKERAkers Biosciences Inc
      05/26/20206:23AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AKERAkers Biosciences Inc
      05/22/20205:02PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AKERAkers Biosciences Inc
      05/21/20203:02PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:AKERAkers Biosciences Inc
      05/19/20206:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
      05/18/20205:33PMGlobeNewswire Inc.Akers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:AKERAkers Biosciences Inc
      05/18/20206:14AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
      05/18/20206:08AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AKERAkers Biosciences Inc
      05/15/20204:12PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AKERAkers Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:AKER